Drug Shortage Report for M-TICAGRELOR
| Report ID | 257750 |
| Drug Identification Number | 02529769 |
| Brand name | M-TICAGRELOR |
| Common or Proper name | Nom commun ou nom propre |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TICAGRELOR |
| Strength(s) | 90MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Taille de l’emballage |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2022-02-02 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-19 | French | Compare |
| v1 | 2025-11-19 | English | Compare |
Showing 1 to 2 of 2